Open0.203 | Close- |
Vol / Avg.418.385K / 797.692K | Mkt Cap2.621M |
Day Range0.185 - 0.207 | 52 Wk Range0.116 - 2.680 |
Sonoma Pharmaceuticals Stock (NASDAQ: SNOA) stock price, news, charts, stock research, profile.
Open0.203 | Close- |
Vol / Avg.418.385K / 797.692K | Mkt Cap2.621M |
Day Range0.185 - 0.207 | 52 Wk Range0.116 - 2.680 |
Q3 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.240 | -0.290 | -0.0500 | ||||
REV | 3.480M | 2.731M | -749.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-05 | Ladenburg Thalmann | Jeff Cohen | Initiates Coverage On | Buy | Announces | - | 3.25 |
2018-07-20 | Benchmark | - | Assumes | Speculative Buy | Announces | - | 3.00 |
2018-03-06 | Maxim Group | Jason Kolbert | Downgrades | BuyHold | Removes | 7.00 | - |
2017-12-28 | Benchmark | - | Initiates Coverage On | Speculative Buy | Announces | - | 10.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
SNOA | Sonoma Pharmaceuticals | -2.89% | 2.6M |
CING | Cingulate | -6.17% | 3.3M |
BFRI | Biofrontera | 0.45% | 5.1M |
TTNP | Titan Pharma | -7.99% | 4.1M |
SXTP | 60 Degrees | 2.65% | 4M |
You can purchase shares of Sonoma Pharmaceuticals (NASDAQ: SNOA) through any online brokerage.
Other companies in Sonoma Pharmaceuticals’s space includes: Cingulate (NASDAQ:CING), Biofrontera (NASDAQ:BFRI), Titan Pharma (NASDAQ:TTNP), 60 Degrees (NASDAQ:SXTP) and Kiora Pharmaceuticals (NASDAQ:KPRX).
The latest price target for Sonoma Pharmaceuticals (NASDAQ: SNOA) was reported by Ladenburg Thalmann on Tuesday, September 5, 2023. The analyst firm set a price target for 3.25 expecting SNOA to rise to within 12 months (a possible 1596.24% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Sonoma Pharmaceuticals (NASDAQ: SNOA) is $0.1916 last updated Today at December 8, 2023 at 5:04 PM UTC.
There is no dividend information for Sonoma Pharmaceuticals.
Sonoma Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, February 13, 2024.
There is no upcoming split for Sonoma Pharmaceuticals.
Sonoma Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.